Komori
TAUNS Laboratories (197A) · TargetRaised

Stable, Sustained Dividends Based on a Payout Ratio of Approximately 30%

First written in FY2024. 3 of 7 entries say "Raised", first in 2026-07-15. Latest entry: FY2026.

7entries
3years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2024ReframedFY20252024: 120242025: 120252026: 52026
Same theme, other companies
Stable and Sustainable Shareholder Returns and Dividend Increase PolicyA theme 1081 companies write about · 2 as a headwind · 1105 as a tailwind

56 other companies' latest entry also says "Raised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 193 companies compared. The sentences above are computed from all 193.Comparing 200 of the theme's 1107 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026RaisedAnnual report

    「During the medium-term management plan period from the fiscal year ending June 2027 through the fiscal year ending June 2031, the company plans to provide stable and sustained returns to shareholders through progressive dividends starting at ¥29.」

    The policy described in the risk section was raised from a starting dividend of ¥28 for the period from the fiscal year ending June 2026 through the fiscal year ending June 2030, as stated in the previous fiscal year, to a starting dividend of ¥29 for the period from the fiscal year ending June 2027 through the fiscal year ending June 2031. Meanwhile, the dividend policy section continues to state a starting dividend of ¥28 for FY2026-2030.
  2. FY2025ReframedAnnual report

    「During the medium-term management plan period from the fiscal year ending June 2026 through the fiscal year ending June 2030, we intend to provide stable and continuous returns by paying progressive dividends starting at ¥28 per share. In addition to our dividend policy, we intend to repurchase shares as necessary after taking into account business conditions and trends in the stock market.」

    The policy changed from targeting a payout ratio of approximately 30% to progressive dividends starting at ¥28 per share from the fiscal year ending June 2026 through the fiscal year ending June 2030. Share repurchases as necessary were also added.
  3. FY2024First statedAnnual report

    「We intend to provide shareholders with stable and continuous returns, targeting a payout ratio of approximately 30%.」

    In addition to regular dividends, the company is considering anniversary commemorative dividends and states that retained earnings will be used for growth investments such as R&D and strengthening the production system.
Moved together

"Construction of a New Mishima Plant and Transition to a Dual-Site Production System" moved the same way as this thread, in the same document, in 3 of its 7 moves.

333222★123456
  1. ★This thread
  2. 1Construction of a New Mishima Plant and Transition to a Dual-Site Production System3×
  3. 2Dependence on Sales of COVID-19-Related Products3×
  4. 3Productivity Gains Through a New Core Business System and Medical Data Platform3×
  5. 4Expansion into non-infectious disease areas, including chronic diseases, cancer and kidney disease2×
  6. 5Overseas Expansion Through Distributor Networks, Overseas-Market Products and High-Value-Added Products2×
  7. 6IP and Technology Partnership Investments Toward the 10-Year Business Vision2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for TAUNS Laboratories yet. It last moved in the General Meetings of Shareholders of 2026-09-02: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Stable, Sustained Dividends Based on a Payout Ratio of Approximately 30% | TAUNS Laboratories,Inc. (197A) | Komori